Accelerating Healthcare & Life Sciences Innovation from Discovery to Deployment.
A premier New York City platform for digital health, AI, medtech, diagnostics, biotech and life sciences innovators entering or scaling in the U.S. market.
An evidence-first launchpad, proven since 1998
For 25+ years, HITLAB’s rigorous, independent research has made health technologies U.S.-ready.
-
Evidence made U.S.- ready
We prepare each innovation's clinical and economic evidence to stand up to the scrutiny of U.S. payers, providers and regulators.
-
Pathways that open doors
HITLAB communications channels and networks unlock new business, alliances, venture capital and grant funding.
-
Impact at national scale
The mission: move breakthrough technologies into U.S. care to improve the lives of 350 million Americans.
Two Decades of Independent Proof
650+ validation studies conducted over 20+ years, with no investment stake, from our New York City base — the credibility U.S. stakeholders trust.
From evidence to U.S. adoption
We help non-U.S. innovators decode the ecosystem, clear regulatory and reimbursement hurdles, and prove their
platform through real-world pilots.
-
U.S. healthcare ecosystem
Map the stakeholders, buyers and care settings that decide whether a technology is adopted.
-
Reimbursement pathways
Identify the coding, coverage and payment routes that make the economics work for U.S. payers.
-
FDA & CMS strategy
Navigate FDA and CMS regulatory pathways and align to the resources each milestone demands.
-
Pilot site relationships
Develop relationships with U.S. pilot sites and health systems ready to test and adopt.
-
IRB & study execution
Lead IRB protocol development, approval and pilot study execution with clinical-research rigor.
-
Adoption & alignment
Align to U.S. customer expectations and drive platform adoption across the health system.
Want to join HealthTech Launchpad?
Get in touch with us to begin your journey
